Additionally, some studies suggest that KLF4 overexpression increases the sensitivity of gastric cancer cells to cisplatin and TRAIL, promoting apoptosis through DR4/DR5 upregulation, enhancing cell death induced by these treatments (78). This evidence concerns the gene KLF4 and gastric cancer.